[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"digital-technology\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:digital-technology":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,4,0,[8,45,82,110],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":29,"overallStatus":34,"whyStopped":4,"lastUpdateSubmitDate":35,"lastUpdatePostDateStruct":36,"startDateStruct":39,"completionDateStruct":40,"leadSponsor":42,"locationsCount":4},"100622766","a-vision-based-characterization-of-human-movement-scaling-in-large-amplitude-tasks-100622766",false,"NCT07387887","A Vision-Based Characterization of Human Movement Scaling in Large-Amplitude Tasks","Inclusion Criteria:\n\nAbility to stand, walk, reach, step, and perform sit-to-stand movements independently without assistance.\n\nNo self-reported or clinically diagnosed neurological, musculoskeletal, or vestibular disorders.\n\nNormal or corrected-to-normal vision sufficient to follow visual instructions.\n\nExclusion Criteria:\n\n* History of neurological disorders (e.g., Parkinson's disease, stroke, multiple sclerosis, traumatic brain injury).\n\nHistory of major musculoskeletal injury or surgery affecting upper or lower extremities that limits movement.\n\nPresence of balance disorders or vestibular dysfunction.\n\nCardiovascular, respiratory, or metabolic conditions that may limit safe participation in physical exercise.\n\nCurrent pain, dizziness, or excessive fatigue during movement or exercise.\n\nPregnancy or any condition for which moderate-intensity physical activity is contraindicated.\n\nUse of assistive devices for walking or balance.\n\nRefusal or inability to provide consent for RGB video recording.",true,"ALL","18 Years","65 Years",{"count":20,"type":21},26,"ESTIMATED","INTERVENTIONAL",[24],"NA","This pilot study investigates the feasibility of objectively quantifying movement amplitude and amplitude decay during large-amplitude exercises using RGB camera-based video analysis in healthy volunteers. Six large-amplitude exercises are recorded across repeated trials, with the first repetition clinically confirmed as the individual's maximum reference. Movement amplitude is quantified using pose-based kinematic measures and complemented by an exploratory self-supervised visual transformer approach to characterize repetition-wise changes relative to the reference execution. The study aims to determine whether camera-based methods can detect amplitude decay patterns and identify moments requiring clinical verbal cues, thereby supporting future objective monitoring and feedback in large-amplitude exercise training.",[27,28],"Digital Technology","Healthy",[30,31,32,33],"Exercise","Motion Analysis","Video-recording","artificial intelligence","NOT_YET_RECRUITING","2026-01-30",{"date":37,"type":38},"2026-02-04","ACTUAL",{"date":35,"type":21},{"date":41,"type":21},"2026-05-30",{"name":43,"class":44},"Biruni University","OTHER",{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":56,"briefSummary":57,"conditions":58,"keywords":64,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":81},"100483704","association-of-a-digital-signature-of-physical-activity-and-sedentary-lifestyle-with-the-development-of-multimorbidities-in-chronic-diseases-emob-100483704","NCT05578495","Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities in Chronic Diseases (eMOB)","Association of a Digital Signature of Physical Activity and Sedentary Lifestyle With the Development of Multimorbidities Over 4 Years of Follow-up in Chronic Diseases (eMOB) : a Prospective Cohort","eMOB","Inclusion Criteria:\n\n* Patient follow-up at CHU Clermont-Ferrand for a chronic disease in one of the following observational cohorts:\n\n  * Inflammatory rheumatic disease(rheumatoid arthritis, spondyloarthritis) included in the RCVRIC cohort (CPP Sud-Est VI N° ID-RCB- A01847-40)\n  * Pre-surgical knee and hip osteoarthritis (Evalmob) (ID-RCB N° 2019- A01017-50)\n  * Major depressive disorder included in the FACE-DR cohort (CNIL agreement: DR- 2015-673) and Bipolar disorder included in the FACE-BD cohort (CPP Ile de France IX; January 18, 2010) of the Adult Psychiatry Department B\n  * Type 2 diabetes included in the cohort of the sport medicine service \"Rehabilitation T2\" (CNIL agreement 0164)\n  * Obesity included in the \"Obesity\" sports medicine service cohort (CNIL agreement 0164)\n  * COPD included in the \"COPD Rehabilitation\" sports medicine service cohort (CNIL agreement 0164)\n  * Chronic pain cohort (eDOL) (CPP West II N° ID-RCB 2020-A02027-32)\n* Affiliation to a social security system.\n* Able to provide written informed consent to participate in the research.\n\nExclusion Criteria:\n\n* Inability to practice physical activity\n* Pregnant or breastfeeding\n* Refusal to participate\n* Minors or adults under the protection of the law or under the protection of justice.","90 Years",{"count":55,"type":21},700,[24],"Physical activity (PA) and sedentary lifestyle are determinants in the development of chronic diseases and associated quality of life alterations. PA levels are correlated with quality of life and morbidity in chronic lung disease (COPD), cardiovascular disease, diabetes, cancer, chronic inflammatory rheumatism, fibromyalgia and anxiety disorders. In these diseases, low-intensity PA often represents the main PA and the quantity of PA is correlated with health parameters.\n\nThis study aims to identify a typical profile (signature) in relation to the appearance of other chronic diseases, complications of your disease, from recording your physical activity and sedentary lifestyle by sensors evaluating very precisely the movements and taking into account the characteristics and disability related to your disease. The results of this study would therefore make it possible to identify this signature even before the appearance of complications or other diseases.",[30,59,60,61,62,63,27],"Sedentary Behavior","Non Communicable Diseases","Comorbidities and Coexisting Conditions","Comorbidity","Multimorbidity",[65,66,67,68,63,69,70],"Physical Activity","Sedentary Lifestyle","Chronic Diseases","Comorbidities","Personal digital health","Personalized medecine","RECRUITING","2025-09-19",{"date":74,"type":38},"2025-09-24",{"date":76,"type":38},"2023-12-07",{"date":78,"type":21},"2030-12",{"name":80,"class":44},"University Hospital, Clermont-Ferrand",1,{"id":83,"slug":84,"hasResults":11,"nctId":85,"briefTitle":86,"officialTitle":87,"acronym":88,"eligibilityCriteria":89,"healthyVolunteers":11,"sex":90,"minAge":17,"maxAge":91,"enrollmentInfo":92,"targetDuration":4,"studyType":22,"phases":94,"briefSummary":95,"conditions":96,"keywords":4,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":101,"lastUpdatePostDateStruct":102,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":5},"100560827","enabling-women-with-parkinsons-disease-to-identify-and-better-manage-hormonal-triggers-of-parkinsonian-symptoms-100560827","NCT06582212","Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers of Parkinsonian Symptoms","Enabling Women with Parkinson's Disease to Identify and Better Manage Hormonal Triggers","Lady-PD","Inclusion Criteria:\n\n* Non-menopausal women\n* Diagnosis of PD according to the MDS criteria onset of PD symptoms since at least two years before inclusion\n* Age 18-56 years\n* On stable medication regimen for PD for at least two months without foreseen need to modify it within the next three months\n* With and without OCP or intrauterine devices (IUD\n\nExclusion Criteria:\n\n* Post-menopausal women with PD\n* Any condition that, in the opinion of the investigator, will preclude the participant from successfully or safely completing study procedures (i.e., dementia, severe depression, etc.)\n* People not able to give an informed consent.","FEMALE","56 Years",{"count":93,"type":21},100,[24],"Forty percent of people living worldwide with Parkinson's disease (PD) are women. Twenty percent of patients have PD onset under the age of 60 years, a time when women may encounter significant caregiving responsibilities along with occupational and other competing demands.\n\nStudies with surveys of women with PD (WwPD) have reported worsening of PDrelated symptoms especially in the week prior and the week of menses. However, prospective evidence is scarce and clinical guidelines to manage this issue do not exist. As a result, care is either non-existent or fragmented.\n\nThe investigators propose a French multicentre prospective pilot study to capture changes in PD symptoms in relation to the stages of the menstrual cycle aiming at reducing hormonal related worsening in PD symptoms through neurologist intervention and\u002For patient selfmanagement.\n\nDigital technology will remotely enable patient reported outcome (PRO) tracking through the My Moves Matter app changes in PD symptoms during several months. This information will then help neurologists to customize treatment.\n\nChanges in motor symptoms will also be highlighted by tracking through the use of a wearable device (PDMonitor) to objectively detect motor changes together with the app.\n\nThis will further support the reliability of the app. This study will provide evidence for the impact of the menstrual cycle on PD and help neurologists and patients to better manage PD symptoms related to these hormonal changes.",[27,97,98,99,100],"Mobile Application","Motor Fluctuations","Oestrogen","Parkinson Disease","2025-03-24",{"date":103,"type":38},"2025-03-25",{"date":105,"type":38},"2025-03-12",{"date":107,"type":21},"2027-09-12",{"name":109,"class":44},"University Hospital, Grenoble",{"id":111,"slug":112,"hasResults":11,"nctId":113,"briefTitle":114,"officialTitle":114,"acronym":4,"eligibilityCriteria":115,"healthyVolunteers":15,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":116,"targetDuration":118,"studyType":119,"phases":4,"briefSummary":120,"conditions":121,"keywords":126,"overallStatus":71,"whyStopped":4,"lastUpdateSubmitDate":131,"lastUpdatePostDateStruct":132,"startDateStruct":134,"completionDateStruct":136,"leadSponsor":138,"locationsCount":81},"100520125","3d-evaluation-of-the-lip-support-in-a-full-arch-implant-supported-rehabilitations-100520125","NCT06052501","3D Evaluation of the Lip Support in a Full-arch Implant-supported Rehabilitations","Inclusion Criteria:\n\n* Individuals with at least a full-arch implant supported rehabilitation in the upper arch\n* Individuals with a provisional or a definitive implant-supported prosthesis\n* Individuals with a stable occlusion function\n* Individuals with compliance to collaborate with the research protocol\n\nExclusion Criteria:\n\n* Individuals with history of hypersensitivity to external light or any similar condition\n* Individuals in an active surgical treatment period\n* Individuals in an active orthodontic treatment in the opposite arch\n* Individuals in an active facial treatment\n* Individuals who did not attend the maintenance visits",{"count":117,"type":21},20,"1 Year","OBSERVATIONAL","The goal of this observational study is to evaluate the impact of a full arch implant-supported prostheses in the lip support. In a complex rehabilitation cases, the process between the diagnosis and the delivery of a prostheses may lead with many clinical and laboratorial choices which influence the final design of the prosthetic work and consequently the facial profile of the patient.\n\nThe use of 3D facial scanners and advanced superimposition methodology allows the investigators to objectively measure several relevant parameters such as vertical occlusion of dimension and lip support.",[27,122,123,124,125],"Prosthesis User","Lip","Oral Soft Tissue Conditions","Occlusion",[127,128,129,130],"three-dimensional imaging","prosthodontics","full-arch","facial scanner","2024-06-24",{"date":133,"type":38},"2024-06-26",{"date":135,"type":38},"2024-03-30",{"date":137,"type":21},"2024-12-15",{"name":139,"class":44},"Implantology Institute"]